JP2019527041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527041A5 JP2019527041A5 JP2018565885A JP2018565885A JP2019527041A5 JP 2019527041 A5 JP2019527041 A5 JP 2019527041A5 JP 2018565885 A JP2018565885 A JP 2018565885A JP 2018565885 A JP2018565885 A JP 2018565885A JP 2019527041 A5 JP2019527041 A5 JP 2019527041A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- seq
- acid sequence
- chain
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU93112 | 2016-06-17 | ||
| LU93112 | 2016-06-17 | ||
| EP17160260.0 | 2017-03-10 | ||
| EP17160260 | 2017-03-10 | ||
| PCT/EP2017/064729 WO2017216324A1 (en) | 2016-06-17 | 2017-06-16 | T cell receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527041A JP2019527041A (ja) | 2019-09-26 |
| JP2019527041A5 true JP2019527041A5 (enExample) | 2020-07-09 |
| JP6989138B2 JP6989138B2 (ja) | 2022-01-05 |
Family
ID=59295160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018565885A Expired - Fee Related JP6989138B2 (ja) | 2016-06-17 | 2017-06-16 | Ｔ細胞受容体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11732020B2 (enExample) |
| EP (1) | EP3472208B9 (enExample) |
| JP (1) | JP6989138B2 (enExample) |
| KR (1) | KR102436129B1 (enExample) |
| CN (1) | CN109715669B (enExample) |
| AU (1) | AU2017286310A1 (enExample) |
| CA (1) | CA3022129A1 (enExample) |
| ES (1) | ES2949342T3 (enExample) |
| WO (1) | WO2017216324A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102016123847B3 (de) * | 2016-12-08 | 2018-04-05 | Immatics Biotechnologies Gmbh | Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie |
| PT3551221T (pt) | 2016-12-08 | 2022-01-18 | Immatics Biotechnologies Gmbh | Novos recetores de células t e imunoterapia empregando os mesmos |
| JP7037577B2 (ja) * | 2017-03-15 | 2022-03-16 | フレッド ハッチンソン キャンサー リサーチ センター | 高親和性ｍａｇｅ－ａ１特異的ｔｃｒ及びその使用 |
| US11236145B2 (en) | 2017-03-23 | 2022-02-01 | Immatics Biotechnologies Gmbh | T cell receptors and immune therapy using the same against PRAME positive cancers |
| DE102017106305A1 (de) | 2017-03-23 | 2018-09-27 | Immatics Biotechnologies Gmbh | Neue T-Zellrezeptoren und deren Verwendung in Immuntherapien gegen prame-positive Krebsarten |
| US20190016802A1 (en) | 2017-07-14 | 2019-01-17 | Immatics Biotechnologies Gmbh | Dual specificity polypeptide molecule |
| RU2694412C9 (ru) | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
| US11919937B2 (en) | 2018-01-09 | 2024-03-05 | Board Of Regents, The University Of Texas System | T cell receptors for immunotherapy |
| CN110272482B (zh) * | 2018-03-14 | 2022-08-19 | 中国科学院广州生物医药与健康研究院 | 识别prame抗原短肽的t细胞受体 |
| CN110818802B (zh) * | 2018-08-08 | 2022-02-08 | 华夏英泰（北京）生物技术有限公司 | 一种嵌合t细胞受体star及其应用 |
| AR117735A1 (es) * | 2018-12-25 | 2021-08-25 | Joint Stock Company Biocad | ANTICUERPOS MONOCLONALES QUE SE UNEN ESPECÍFICAMENTE A LA REGIÓN b DE LA FAMILIA TRBV-9 DEL RECEPTOR DE CÉLULAS T HUMANO, Y LOS MÉTODOS PARA SU USO |
| SG11202110956RA (en) | 2019-04-05 | 2021-10-28 | Rootpath Genomics Inc | Compositions and methods for t-cell receptor gene assembly |
| CN115103852B (zh) * | 2019-11-18 | 2026-01-02 | 德国生物新技术公司 | Prame tcr受体和其用途 |
| CN110964122B (zh) * | 2019-12-24 | 2022-04-15 | 南京北恒生物科技有限公司 | T细胞受体融合蛋白及其用途 |
| CN115485294A (zh) * | 2020-03-27 | 2022-12-16 | 2赛文缇生物公司 | T细胞受体 |
| CN111690051B (zh) * | 2020-06-28 | 2021-08-17 | 英威福赛生物技术有限公司 | 靶向ny-eso-1(157-165)表位的特异性t细胞受体及抗肿瘤应用 |
| EP4227316A4 (en) * | 2020-10-07 | 2025-07-30 | Daan Biotherapeutics Co., Ltd. | T CELL RECEPTOR, IMMUNE CELL COMPRISING T CELL RECEPTOR, AND METHOD USING THE SAME |
| AU2022270361A1 (en) | 2021-05-05 | 2023-11-16 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
| EP4334331A1 (en) * | 2021-05-07 | 2024-03-13 | Medigene Immunotherapies GmbH | Combination of prame specific t cell receptors and chimeric co-stimulatory receptors |
| EP4419548A4 (en) * | 2021-10-18 | 2025-12-17 | Univ Texas | PEPTIDES AND MANIPULATED T-CELL RECEPTORS FOR TARGETTING NDC80 ANTIGEN AND METHOD FOR USE |
| WO2023175069A1 (en) | 2022-03-16 | 2023-09-21 | Medigene Immunotherapies Gmbh | Tcr constant region pairing library for pramevld tcrs |
| US20250205335A1 (en) * | 2022-03-17 | 2025-06-26 | Hangzhou Chengyuan Biotechnology Co., Ltd. | Synthetic tumor-infiltrating lymphocytes (tils) |
| WO2024092265A2 (en) * | 2022-10-28 | 2024-05-02 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting ewsr1-wt1 fusion protein and uses thereof |
| WO2024123975A2 (en) * | 2022-12-07 | 2024-06-13 | Board Of Regents, The University Of Texas System | A t cell receptor recognizing an unmutated foxm1 epitope presented on hla-a*02:01 |
| WO2024163292A1 (en) * | 2023-01-30 | 2024-08-08 | Board Of Regents, The University Of Texas System | T-cell receptors targeting her2 and methods of use thereof |
| CN118221811B (zh) * | 2023-08-25 | 2025-05-30 | 立凌生物制药(苏州)有限公司 | 靶向prame多肽的单域抗体及其用途 |
| WO2025247325A1 (en) * | 2024-05-30 | 2025-12-04 | Hanx Biopharmaceuticals, (Wuhan) Ltd. | Antibody-drug conjugates targeting trbv12 and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1118860A1 (en) * | 2000-01-21 | 2001-07-25 | Rijksuniversiteit te Leiden | Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| CA2518371A1 (en) * | 2003-03-14 | 2004-09-30 | Wyeth | Antibodies against human il-21 receptor and uses therefor |
| EP2006376A1 (en) | 2007-06-21 | 2008-12-24 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| WO2009026116A2 (en) | 2007-08-16 | 2009-02-26 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| CN103764826A (zh) | 2011-06-28 | 2014-04-30 | 株式会社癌免疫研究所 | 肽癌抗原-特异性t细胞的受体基因 |
-
2017
- 2017-06-16 CN CN201780036677.2A patent/CN109715669B/zh not_active Expired - Fee Related
- 2017-06-16 AU AU2017286310A patent/AU2017286310A1/en not_active Abandoned
- 2017-06-16 JP JP2018565885A patent/JP6989138B2/ja not_active Expired - Fee Related
- 2017-06-16 CA CA3022129A patent/CA3022129A1/en active Pending
- 2017-06-16 WO PCT/EP2017/064729 patent/WO2017216324A1/en not_active Ceased
- 2017-06-16 ES ES17736576T patent/ES2949342T3/es active Active
- 2017-06-16 EP EP17736576.4A patent/EP3472208B9/en active Active
- 2017-06-16 US US16/309,902 patent/US11732020B2/en active Active
- 2017-06-16 KR KR1020187037617A patent/KR102436129B1/ko active Active
-
2023
- 2023-08-21 US US18/236,327 patent/US20240083967A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019527041A5 (enExample) | ||
| TWI828625B (zh) | 引導及導航控制蛋白質以及彼之製造及使用方法 | |
| JP6640726B2 (ja) | キメラ抗原受容体及びその製造方法 | |
| JP7573441B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| RU2018107802A (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| Inaguma et al. | Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H | |
| JP2018529327A5 (enExample) | ||
| Boettcher et al. | Development of CAR T cell therapy in children—A comprehensive overview | |
| RU2018105963A (ru) | Антитело против глипикана-3 и его применение | |
| JOP20190248A1 (ar) | بروتينات ربط مولد ضد trem2 واستخداماته | |
| JP2015527070A5 (enExample) | ||
| RU2017121826A (ru) | Т-клетки, модифицированные химерным рецептором антигена, нацеленным на cs1 | |
| EP3471770A1 (en) | Tunable chimeric antigen receptors | |
| EA201590216A1 (ru) | Способы оценки пригодности трансдуцированных t-клеток для введения | |
| Gu et al. | Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A* 11: 01 | |
| JP2017537972A5 (enExample) | ||
| JP2019525771A5 (enExample) | ||
| NZ759969A (en) | Tagged chimeric effector molecules and receptors thereof | |
| RU2017133637A (ru) | Иммуномодулирующие слитые белки и пути их применения | |
| RU2018113510A (ru) | Химерные рецепторы антигена, нацеленные на psca | |
| JP2018508219A5 (enExample) | ||
| RU2013147157A (ru) | Способ и композиции для клеточной иммунотерапии | |
| RU2017111298A (ru) | Т-КЛЕТКИ С КОСТИМУЛИРУЮЩИМ ХИМЕРНЫМ АНТИГЕННЫМ РЕЦЕПТОРОМ, НАЦЕЛЕННЫЕ НА IL13Rα2 | |
| JP2018528786A5 (enExample) | ||
| Fujiwara | Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors |